Mycostatin (Nystatin)

Nystatin binds to ergosterol in fungal cell membranes, forming pores that increase membrane permeability. This leads to leakage of essential intracellular components, causing fungal cell death while sparing human cells that lack ergosterol.

The appropriate dose of Mycostatin is determined by the prescribing clinician based on the specific infection, patient age, weight and renal or hepatic function. Dosage instructions are provided on the prescription label and should be followed exactly.

Safety data for nystatin in pregnancy and lactation are limited. Mycostatin should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision should be made by a qualified healthcare professional.

To order Mycostatin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mycostatin (nystatin) is a polyene antifungal that acts locally in the gastrointestinal tract, unlike systemic azoles such as fluconazole which are absorbed and distributed throughout the body. Nystatin is often preferred for superficial or localized Candida infections because it has minimal systemic absorption and a distinct safety profile.

Mycostatin should be stored below 25 °C, in its original packaging, and protected from moisture. Keeping the product in a cool, dry place helps maintain its stability and potency throughout its shelf life.

Mycostatin is taken orally as directed by a healthcare professional. The formulation may be a liquid suspension or tablet; it should be swallowed with water or mixed with a suitable vehicle as indicated on the prescription label.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis, hepatotoxicity, nephrotoxicity, and significant hematologic abnormalities. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, swelling, jaundice, dark urine or unexplained bruising.

Mycostatin should be avoided in individuals with known hypersensitivity to nystatin or any component of the formulation. Caution is also advised for patients with severe renal or hepatic impairment, and it should be used only under medical supervision in such cases.